X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (238) 238
male (158) 158
female (149) 149
middle aged (121) 121
index medicus (117) 117
aged (113) 113
gastroenterology & hepatology (111) 111
hepatocellular carcinoma (79) 79
adult (72) 72
aged, 80 and over (63) 63
liver neoplasms - pathology (61) 61
liver cancer (57) 57
carcinoma, hepatocellular - pathology (55) 55
cirrhosis (53) 53
cancer (48) 48
oncology (45) 45
ultrasonography (45) 45
hepatoma (41) 41
liver (41) 41
liver cirrhosis (39) 39
diagnosis (34) 34
digestive system diseases (32) 32
retrospective studies (32) 32
carcinoma, hepatocellular - drug therapy (30) 30
liver neoplasms - drug therapy (30) 30
management (28) 28
survival (27) 27
care and treatment (26) 26
gastroenterology and hepatology (26) 26
liver cirrhosis - complications (26) 26
neoplasm staging (26) 26
liver neoplasms - genetics (25) 25
treatment outcome (24) 24
carcinoma, hepatocellular - genetics (23) 23
carcinoma, hepatocellular - mortality (23) 23
liver neoplasms - diagnostic imaging (23) 23
liver neoplasms - mortality (23) 23
prognosis (23) 23
hepatology (22) 22
analysis (21) 21
cell line, tumor (21) 21
expression (21) 21
prospective studies (21) 21
medicine, general & internal (20) 20
radiology, nuclear medicine & medical imaging (20) 20
risk factors (20) 20
sorafenib (20) 20
carcinoma, hepatocellular - surgery (19) 19
carcinoma, hepatocellular - therapy (19) 19
contrast media (19) 19
liver neoplasms - surgery (19) 19
liver neoplasms - therapy (19) 19
time factors (19) 19
ultrasound (19) 19
internal medicine (18) 18
liver cirrhosis - pathology (18) 18
medicine & public health (18) 18
therapy (18) 18
tumors (18) 18
animals (17) 17
carcinoma, hepatocellular - diagnosis (17) 17
carcinoma, hepatocellular - metabolism (17) 17
liver cirrhosis - physiopathology (17) 17
liver neoplasms - diagnosis (17) 17
acoustics (16) 16
disease (16) 16
gastroenterology (16) 16
guidelines (16) 16
liver - diagnostic imaging (16) 16
liver neoplasms (16) 16
liver transplantation (16) 16
niacinamide - analogs & derivatives (16) 16
carcinoma, hepatocellular (15) 15
disease progression (15) 15
gene expression regulation, neoplastic (15) 15
liver neoplasms - metabolism (15) 15
surgery (15) 15
apoptosis (14) 14
biopsy (14) 14
liver - pathology (14) 14
magnetic resonance imaging (14) 14
microrna (14) 14
prevalence (14) 14
transplantation (14) 14
carcinoma, hepatocellular - diagnostic imaging (13) 13
chemistry (13) 13
diagnosis, differential (13) 13
follow-up studies (13) 13
italy (13) 13
italy - epidemiology (13) 13
liver-transplantation (13) 13
p53 (13) 13
survival analysis (13) 13
young adult (13) 13
adolescent (12) 12
cell biology (12) 12
chemotherapy (12) 12
kaplan-meier estimate (12) 12
liver neoplasms - complications (12) 12
rats (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1344 - 1354
Summary Background There is no standard of care for adjuvant therapy for patients with hepatocellular carcinoma. This trial was designed to assess the efficacy... 
Hematology, Oncology and Palliative Medicine | CLINICAL-PRACTICE GUIDELINES | DIAGNOSIS | LIVER-TRANSPLANTATION | RISK-FACTORS | THERAPY | MANAGEMENT | ONCOLOGY | SAFETY | PREVENTION | RECURRENCE | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 1, pp. 54 - 63
Journal Article
Journal Article
Internal and Emergency Medicine, ISSN 1828-0447, 10/2014, Volume 9, Issue 7, pp. 723 - 734
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 4, pp. 378 - 390
Journal Article